Economic development roadmap for bioscience in Iowa identifies four platforms

bioscience (2)The following is an excerpt from a December 19, 2017 Governor’s press release.

Gov. Kim Reynolds and Lt. Gov. Adam Gregg, along with representatives from the Iowa Economic Development Authority (IEDA) and Iowa Innovation Council (IIC), released an economic development roadmap for Iowa’s bioscience industry during a December 19th news conference.  IEDA and IIC hired TEConomy Partners, LLC to do an in-depth analysis on Iowa’s bioscience industry. This is the state’s third bioscience report and most extensive to date, building on a baseline report done in 2004 and a progress report done in 2011.

Over the past year and a half, TEConomy researchers examined Iowa’s current position in comparison with the rest of the nation. According to the report, Iowa has 36 percent more employment in bioscience than the national average.

“Iowa is fortunate to have a strong bioscience industry,” Gov. Reynolds said. “These business leaders lend their expertise to ensure our state has a focused plan for success. We appreciate their leadership and understand the importance of this report to Iowa’s economic future.”

The report identifies four platforms as the future of Iowa’s bioscience development: medical devices; biobased chemicals; precision and digital agriculture; and vaccines and immunotherapeutics.

Read the Governor’s releasedownload the executive summary and full report.